Behind the Mystery
A specialized, recurring segment devoted to rare and genetic diseases, Behind The Mystery highlights the emotional, scientific, and medical aspects associated with rare and genetic diseases. We clarify the often-complex issues by offering easy-to-understand explanations from top experts in the field. Our goal is to expand awareness for rare and genetic diseases through partnerships with pharmaceutical and biotech companies while giving voices to the patients, families, and advocates affected via our national television platform.
Latest Stories
PROMOTED
LGS is a rare neurodevelopmental disorder that evolves over time in very young children from treatment-resistant seizures.
PROMOTED
The EB Research Partnership is the largest global organization dedicated to funding research to treat and cure Epidermolysis Bullosa or EB.
PROMOTED
Primary HLH is a rare, rapidly progressive, and fatal disorder with a median survival of less than 2 months.
PROMOTED
iMCD is the deadliest subtype of Castleman disease. Approximately one third of patients die within five years of diagnosis, and another third die within 10 years if not treated.
PROMOTED
There are no effective treatment options for people with unresectable or metastatic chondrosarcoma despite many attempts by multiple pharmaceutical companies over the past few decades.
PROMOTED
We're going Behind the Mystery of two rare diseases: Castleman disease and chondrosarcoma.
PROMOTED
Systemic Mastocytosis (SM) is characterized by the overactivity and build-up of mast cells throughout the body. Learn more now.
PROMOTED
NRG1 fusions, a rare cancer target, may unlock new potential options for doctors and patients.
PROMOTED
Wilson disease is a rare, chronic disorder characterized by copper accumulation in organs and tissues that, if left untreated, may result in liver, neurologic, and psychiatric symptoms that progress over time. To understand more about how this disease affects patients, we met with Ed, who waited over 50 years for a diagnosis. He details the […]
